• Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
Close Search
00
GBAF LogoGBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
GBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Top Stories

    Posted By Gbaf News

    Posted on May 25, 2017

    Featured image for article about Top Stories
    • The new funds will support the company’s expansion into Latin America, the development of advanced software for doctors and marketing and sales activities in core markets
    • London-based One Peak Partners joins existing investors Target Global and ENERN Investments in the round
    • This round brings total raised by DocPlanner to approximately €46 million

    Healthcare booking platform DocPlanner has today announced the closing of a €15 million Series D financing round, just ten months after announcing a Series C round of $20 million and successfully merging with Spanish healthcare platform Doctoralia. This brings the total raised by DocPlanner to approximately €46 million, and further marks the company’s progress to become the leading healthcare platform globally.

    The new round is led by existing shareholder ENERN Investments; Target Global, another existing investor, and London-based One Peak Partners round out the syndicate. The investment will be used to fund new offices in Brazil and Mexico over the next six months as well as marketing and sales in DocPlanner’s core markets in Southern Europe and Latin America.

    The Poland-based company is also actively expanding its SaaS capabilities with the aim of providing more advanced solutions to doctor practices. The company has not ruled out bolt-on acquisitions of young, innovative cloud-based software companies to accelerate this process.

    MariuszGralewski, founder and CEO of DocPlanner, said:

    “We continue the process of integrating the DocPlanner and Doctoralia teams and have already developed a very coherent and well-functioning organisation with a common mission and strategy. We have been able to take the best practices and capabilities from each business to create something that is way beyond the sum of its parts.”

    “In addition to consolidating our presence in core markets, our goal with the new funding is to expand our offering to doctors by moving beyond the calendar management. This will also help us accomplish our global mission to ‘make the healthcare experience more human’.”

    Pavel Mucha, Partner at ENERN Investments commented:

    “We believe the time has come for uprising SaaS technologies to change the way we interact with doctors and manage our health, which will greatly advance the quality of life around the world. DocPlanner can make a global dent.”

    Humbert de Liedekerke, Managing Partner of One Peak Partners added:

    “Behind the success of DocPlanner lies the ambition to help millions of patients make better healthcare decisions. We look forward to building on the considerable success already achieved by management and supporting the company in creating a category-defining, global leader.”

    • The new funds will support the company’s expansion into Latin America, the development of advanced software for doctors and marketing and sales activities in core markets
    • London-based One Peak Partners joins existing investors Target Global and ENERN Investments in the round
    • This round brings total raised by DocPlanner to approximately €46 million

    Healthcare booking platform DocPlanner has today announced the closing of a €15 million Series D financing round, just ten months after announcing a Series C round of $20 million and successfully merging with Spanish healthcare platform Doctoralia. This brings the total raised by DocPlanner to approximately €46 million, and further marks the company’s progress to become the leading healthcare platform globally.

    The new round is led by existing shareholder ENERN Investments; Target Global, another existing investor, and London-based One Peak Partners round out the syndicate. The investment will be used to fund new offices in Brazil and Mexico over the next six months as well as marketing and sales in DocPlanner’s core markets in Southern Europe and Latin America.

    The Poland-based company is also actively expanding its SaaS capabilities with the aim of providing more advanced solutions to doctor practices. The company has not ruled out bolt-on acquisitions of young, innovative cloud-based software companies to accelerate this process.

    MariuszGralewski, founder and CEO of DocPlanner, said:

    “We continue the process of integrating the DocPlanner and Doctoralia teams and have already developed a very coherent and well-functioning organisation with a common mission and strategy. We have been able to take the best practices and capabilities from each business to create something that is way beyond the sum of its parts.”

    “In addition to consolidating our presence in core markets, our goal with the new funding is to expand our offering to doctors by moving beyond the calendar management. This will also help us accomplish our global mission to ‘make the healthcare experience more human’.”

    Pavel Mucha, Partner at ENERN Investments commented:

    “We believe the time has come for uprising SaaS technologies to change the way we interact with doctors and manage our health, which will greatly advance the quality of life around the world. DocPlanner can make a global dent.”

    Humbert de Liedekerke, Managing Partner of One Peak Partners added:

    “Behind the success of DocPlanner lies the ambition to help millions of patients make better healthcare decisions. We look forward to building on the considerable success already achieved by management and supporting the company in creating a category-defining, global leader.”

    Recommended for you

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe